Paying the right price for pharmaceuticals: a case study of why the comparator matters

No Thumbnail Available
File version
Author(s)
Spinks, Jean M
Richardson, Jeff RJ
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2011
Size
File type(s)
Location
License
Abstract

This article considers the pricing policy for pharmaceuticals in Australia, which is widely seen as having achieved low drug prices. However, compared to New Zealand, the evidence implies that Australia might have improved its performance significantly if it had proactively sought market best pricing. The Australian record suggests that the information sought by authorities may not be sufficient for optimal pricing and that the economic evaluation of pharmaceuticals may be neither necessary nor sufficient for achieving this goal.

Journal Title

Australian Health Review

Conference Title
Book Title
Edition
Volume

35

Issue

3

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Medical and Health Sciences not elsewhere classified

Persistent link to this record
Citation
Collections